bf/NASDAQ:ICVX_icon.jpeg

    COM:ICOSAVAX

    Icosavax, Inc.

    • Stock

    15.31

    −0.91%

    −0.14

    USD last updated 01/04 01:29:30

    Last Close

    15.45

    16/02 21:00

    Market Cap

    769.04M

    Beta: -

    Volume Today

    8.56M

    Avg: -

    • name

      Icosavax, Inc.
    • homepage url

      icosavax.com
    • country

      USUnited States
    • crunchbase url

      icosavax
    • employee count

      60
    • sector

      Healthcare
    • industry

      Biotechnology

    Description

    Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory syncyt...Show More

    investor of